Key terms
About HUMA
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HUMA news
Apr 08
8:25am ET
Oppenheimer Keeps Their Buy Rating on Humacyte (HUMA)
Apr 03
1:44pm ET
Humacyte management to meet with BTIG
Mar 28
4:35pm ET
Humacyte’s HAV: A Game-Changer for Underserved Hemodialysis Patients
Mar 26
7:06am ET
Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)
Mar 25
7:40am ET
Analysts Are Bullish on Top Healthcare Stocks: CareCloud (CCLD), AbSci (ABSI)
Mar 23
10:35am ET
Humacyte’s Strong Outlook: Buy Rating Affirmed Amid Advancements and Market Opportunity
Mar 22
1:35pm ET
Buy Rating for Humacyte: Anticipated FDA Approval and Strong Financials Signal Growth Potential
Mar 22
8:06am ET
Options Volatility and Implied Earnings Moves Today, March 22, 2024
Mar 22
7:03am ET
Humacyte reports Q4 EPS (24c), consensus (24c)
Mar 08
7:59am ET
Humacyte price target raised to $4 from $3 at Piper Sandler
Mar 08
7:48am ET
Piper Sandler Reaffirms Their Hold Rating on Humacyte (HUMA)
Mar 01
6:21am ET
Humacyte 13.4M share Spot Secondary priced at $3.00
Feb 29
4:03pm ET
Humacyte announces common stock offering, no amount given
Feb 12
4:39am ET
3 Best Stocks to Buy Now, 2/12/2024, According to Top Analysts
Feb 11
12:01pm ET
Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC), Mettler-Toledo (MTD) and Humacyte (HUMA)
Feb 10
4:07am ET
Humacyte Receives FDA Priority Review for Vascular Repair Solution
Feb 09
1:25pm ET
Buy Rating Justified by FDA Review and Commercial Prospects for Humacyte’s HAV Device
Feb 09
8:02am ET
Humacyte announces U.S. FDA accepted, granted priority review to BLA of HAV
Jan 19
6:28am ET
5 Top Penny Stocks to Buy Now, According to Analysts – January 2024
No recent press releases are available for HUMA
HUMA Financials
Key terms
Ad Feedback
HUMA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HUMA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
